Synthesis and delivery of capsular polysaccharides by recombinant attenuated vaccines.

Proc Natl Acad Sci U S A

College of Veterinary Medicine, Southwest University, Chongqing 400715, China;

Published: January 2021

AI Article Synopsis

  • Capsular polysaccharides (CPSs) are key factors in bacterial pathogenicity and are used in pneumococcal vaccines like Pneumovax and Prevnar, greatly reducing diseases in developed nations.
  • Traditional vaccine production is expensive and not scalable for developing countries, prompting the need for a more affordable solution.
  • This study proposes a new low-cost live vaccine using a recombinant attenuated system, successfully eliciting strong immune responses in mice and showing effective protection against pneumococcal infections.

Article Abstract

capsular polysaccharides (CPSs) are major determinants of bacterial pathogenicity. CPSs of different serotypes form the main components of the pneumococcal vaccines Pneumovax, Prevnar7, and Prevnar13, which substantially reduced the disease burden in developed countries. However, the laborious production processes of traditional polysaccharide-based vaccines have raised the cost of the vaccines and limited their impact in developing countries. The aim of this study is to develop a kind of low-cost live vaccine based on using the recombinant attenuated vaccine (RASV) system to protect against pneumococcal infections. We cloned genes for seven different serotypes of CPSs to be expressed by the RASV strain. Oral immunization of mice with the RASV-CPS strains elicited robust Th1 biased adaptive immune responses. All the CPS-specific antisera mediated opsonophagocytic killing of the corresponding serotype of in vitro. The RASV-CPS2 and RASV-CPS3 strains provided efficient protection of mice against challenge infections with either strain D39 or WU2. Synthesis and delivery of CPSs using the RASV strains provide an innovative strategy for low-cost pneumococcal vaccine development, production, and use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812815PMC
http://dx.doi.org/10.1073/pnas.2013350118DOI Listing

Publication Analysis

Top Keywords

synthesis delivery
8
capsular polysaccharides
8
recombinant attenuated
8
delivery capsular
4
polysaccharides recombinant
4
vaccines
4
attenuated vaccines
4
vaccines capsular
4
cpss
4
polysaccharides cpss
4

Similar Publications

Background: Digital mental health interventions (DMHIs) to monitor and improve the health of people with psychosis or bipolar disorder show promise; however, user engagement is variable, and integrated clinical use is low.

Objective: This prospectively registered systematic review examined barriers and facilitators of clinician and patient engagement with DMHIs, to inform implementation within real-world settings.

Methods: A systematic search of 7 databases identified empirical studies reporting qualitative or quantitative data about factors affecting staff or patient engagement with DMHIs aiming to monitor or improve the mental or physical health of people with psychosis or bipolar disorder.

View Article and Find Full Text PDF

Neurodegenerative diseases (NDs) are caused by progressive neuronal death and cognitive decline. Epigallocatechin 3-gallate (EGCG) is a polyphenolic molecule in green tea as a neuroprotective agent. This review evaluates the therapeutic effects of EGCG and explores the molecular mechanisms that show its neuroprotective properties.

View Article and Find Full Text PDF

Introduction: Genomic medicine has features that make it preference sensitive and amenable to model-based health economic evaluation. Preferences of patients, caregivers, and clinicians related to the uptake and delivery of genomic medicine technologies and services that are not captured in health state utility weights can affect the intervention's cost-effectiveness and budget impact. However, there is currently no established or agreed-on approach for integrating preference information into economic evaluations.

View Article and Find Full Text PDF

This review explores the intricate connections between Drosophila models and the human blood-brain barrier (BBB) with nanoparticle-based approaches for neurological treatment. Drosophila serves as a powerful model organism due to its evolutionary conservation of key biological processes, particularly in the context of the BBB, which is formed by glial cells that share structural and functional similarities with mammalian endothelial cells. Recent advancements in nanoparticle technology have highlighted their potential for effective drug delivery across the BBB, utilizing mechanisms such as passive diffusion, receptor-mediated transcytosis, and carrier-mediated transport.

View Article and Find Full Text PDF

Chirality of sub-nanometer nanowires/nanobelts.

Nanoscale

January 2025

School of Chemistry and Chemical Engineering, Beijing Institution of Technology (BIT), Beijing 100081, P. R. China.

Chirality is a widespread phenomenon in the fields of nature and chemicals, endowing compounds with distinctive chemical and biological characteristics. The conventional synthesis of chiral nanomaterials relies on the introduction of chiral ligands or additives and environmental factors such as solvents and mechanical forces. Sub-nanometer nanowires (SNWs) and sub-nanometer nanobelts (SNBs) are one-dimensional nanomaterials with high anisotropy, nearly 100% atomic exposure ratio and some other distinctive characteristics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!